These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29590657)

  • 1. Angiotensin II Suppresses Rev-erbα Expression in THP-1 Macrophages via the Ang II Type 1 Receptor/Liver X Receptor α Pathway.
    Wang S; Gu X; Zhang Q; Zhang X; Li Y; Yao Y; Yu B; Zhang Y
    Cell Physiol Biochem; 2018; 46(1):303-313. PubMed ID: 29590657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
    Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rev-erbα activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice.
    Yuan X; Dong D; Li Z; Wu B
    Pharmacol Res; 2019 Mar; 141():310-318. PubMed ID: 30639375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression.
    Sato S; Sakurai T; Ogasawara J; Takahashi M; Izawa T; Imaizumi K; Taniguchi N; Ohno H; Kizaki T
    J Immunol; 2014 Jan; 192(1):407-17. PubMed ID: 24307731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
    Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome.
    Hong H; Cheung YM; Cao X; Wu Y; Li C; Tian XY
    Biochem Pharmacol; 2021 Oct; 192():114701. PubMed ID: 34324866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-(1-7) upregulates expression of adenosine triphosphate-binding cassette transporter A1 and adenosine triphosphate-binding cassette transporter G1 through the Mas receptor through the liver X receptor alpha signalling pathway in THP-1 macrophages treated with angiotensin-II.
    Liang B; Wang X; Bian Y; Yang H; Liu M; Bai R; Yang Z; Xiao C
    Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1023-30. PubMed ID: 25225013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway.
    Yang LX; Ye JS; Guo RW; Liu H; Wang XM; Qi F; Guo C
    Inflamm Res; 2010 Dec; 59(12):1033-40. PubMed ID: 20563831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling.
    Yang HY; Bian YF; Xiao CS; Liang B; Zhang N; Gao F; Yang ZM
    Mol Med Rep; 2015 Jul; 12(1):1387-92. PubMed ID: 25779847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
    Kanome T; Watanabe T; Nishio K; Takahashi K; Hongo S; Miyazaki A
    Hypertens Res; 2008 Sep; 31(9):1801-10. PubMed ID: 18971559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activation of rev-erbα suppresses LPS-induced macrophage M1 polarization and prevents pregnancy loss.
    Cui L; Xu F; Wang S; Li X; Lin H; Ding Y; Du M
    BMC Immunol; 2021 Aug; 22(1):57. PubMed ID: 34399700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect suppression of interleukin-6 gene expression in murine macrophages by nuclear orphan receptor REV-ERBα.
    Sato S; Sakurai T; Ogasawara J; Shirato K; Ishibashi Y; Oh-ishi S; Imaizumi K; Haga S; Hitomi Y; Izawa T; Ohira Y; Ohno H; Kizaki T
    ScientificWorldJournal; 2014; 2014():685854. PubMed ID: 25401152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear receptor Rev-erbalpha is a liver X receptor (LXR) target gene driving a negative feedback loop on select LXR-induced pathways in human macrophages.
    Fontaine C; Rigamonti E; Pourcet B; Duez H; Duhem C; Fruchart JC; Chinetti-Gbaguidi G; Staels B
    Mol Endocrinol; 2008 Aug; 22(8):1797-811. PubMed ID: 18511497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythm-associated Rev-erbα modulates polarization of decidual macrophage via the PI3K/Akt signaling pathway.
    Cui L; Jin X; Xu F; Wang S; Liu L; Li X; Lin H; Du M
    Am J Reprod Immunol; 2021 Sep; 86(3):e13436. PubMed ID: 33934423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
    Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
    Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clock gene Rev-erbα regulates pancreatic β-cell function: modulation by leptin and high-fat diet.
    Vieira E; Marroquí L; Batista TM; Caballero-Garrido E; Carneiro EM; Boschero AC; Nadal A; Quesada I
    Endocrinology; 2012 Feb; 153(2):592-601. PubMed ID: 22166979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.
    Shen W; Zhang W; Ye W; Wang H; Zhang Q; Shen J; Hong Q; Li X; Wen G; Wei T; Zhang J
    Theranostics; 2020; 10(10):4466-4480. PubMed ID: 32292508
    [No Abstract]   [Full Text] [Related]  

  • 19. REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis.
    Le Martelot G; Claudel T; Gatfield D; Schaad O; Kornmann B; Lo Sasso G; Moschetta A; Schibler U
    PLoS Biol; 2009 Sep; 7(9):e1000181. PubMed ID: 19721697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased atherosclerotic lesions in LDL receptor deficient mice with hematopoietic nuclear receptor Rev-erbα knock- down.
    Ma H; Zhong W; Jiang Y; Fontaine C; Li S; Fu J; Olkkonen VM; Staels B; Yan D
    J Am Heart Assoc; 2013 Aug; 2(4):e000235. PubMed ID: 23963755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.